Ihn Hironobu
Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University.
Nihon Rinsho. 2009 Mar;67(3):519-22.
Systemic sclerosis (SSc), the focus of this review, is a generalized connective tissue disease that involves sclerotic changes in the skin and sometimes various other organ systems. Clinical outcomes have improved probably due to better management of the complications, but SSc is still considered to be incurable and diffuse cutaneous SSc carries high risk of fatality. Although the pathogenesis of SSc is still unknown, the basic mechanism appears to involve endothelial cell injury, overproduction of extracellular matrix (ECM), and aberrant immune activation. This review discusses recent studies that investigated the cellular and molecular mechanisms in the pathogenesis of SSc.
系统性硬化症(SSc)是本综述的重点,它是一种全身性结缔组织疾病,涉及皮肤的硬化改变,有时还累及其他各种器官系统。由于对并发症的管理有所改善,临床结局可能已有所改善,但SSc仍被认为无法治愈,弥漫性皮肤型SSc具有很高的致死风险。尽管SSc的发病机制尚不清楚,但其基本机制似乎涉及内皮细胞损伤、细胞外基质(ECM)过度产生和异常免疫激活。本综述讨论了近期研究,这些研究调查了SSc发病机制中的细胞和分子机制。